Henry A. Nasrallah - Concepedia

Author

Henry A. Nasrallah

Also Known As

Davis, Vicki G., H A Nasrallah, H NASRALLAH, H Nasrallah, H. A. Nasrallah, H. Nasrallah, H.A. Nasrallah, HENRY A. NASRALLAH, Henry A Nasrallah, Henry A. Nasrallah

525

Publications

21.1K

Citations

H-Index

188

Concepts

All Affiliations

The Ohio State University University of Cincinnati Medical Center University of Cincinnati University of Iowa Saint Louis University

About

Henry A. Nasrallah is an author at The Ohio State University specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	128	10.5K
2	Health Sciences	8	8	264
3	Education	3	3	98
4	Engineering	2	2	36
5	Language Studies	1	1	149

Henry A. Nasrallah

177

Publications

13.3K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III Joseph P. McEvoy, Jonathan M. Meyer, Donald Goff, Schizophrenia Research Intervention EffectivenessMetabolic SyndromeMetabolic DisorderPsychiatryPsychotic Disorder	2005	1.1K
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline Henry A. Nasrallah, Jonathan M. Meyer, Donald Goff, Schizophrenia Research HypertensionPsychiatryAntihypertensive TherapyDiabetesSchizophrenia	2006	553
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls Donald Goff, Lisa Sullivan, Joseph P. McEvoy, Schizophrenia Research Risk PredictionPsychiatryCardiovascular DiseasePsychotic DisorderCatie Study	2005	526
Handbook of Affective Disorders Henry A. Nasrallah The Journal of Nervous and Mental Disease PsychopathologyPsychiatryEmotion RegulationMood SymptomAffective Neuroscience	1993	444
A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia Henry A. Nasrallah, Nancy C. Andreasen, Jeffrey A. Coffman, Biological Psychiatry PsychiatryPsychotic DisorderNeuroanatomyWhite MatterMagnetic Resonance	1986	288
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1 Jonathan M. Meyer, Vicki G. Davis, Donald Goff, Schizophrenia Research Catie Schizophrenia TrialMetabolic SyndromePsychiatryPsychotic DisorderPsychotropic Medication	2008	285
Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology Anilkumar Pillai, Anvita Kale, Sadhana Joshi, The International Journal of Neuropsychopharmacology NeuropsychologyPsychopathologyPsychopharmacologyNeuropsychiatrySocial Sciences	2009	269
Cognitive impairment and cerebral structure by MRI in bipolar disorder Jeffrey A. Coffman, Robert A. Bornstein, Stephen C. Olson, Biological Psychiatry Neuroimaging BiomarkersNeuropsychologyNeuroimaging ModalityPsychiatryMedicine	1990	245
Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 Diabetes Frank D. Gianfrancesco, Amy Grogg, Ramy Mahmoud, The Journal of Clinical Psychiatry	2002	237
Suicide Note Classification Using Natural Language Processing: A Content Analysis John Pestian, Henry A. Nasrallah, Paweł Matykiewicz, Biomedical Informatics Insights	2010	236

Page 1